Please login to the form below

From promise to practice: immuno-oncology in action Part 3 - Emerging Markets

Our latest white paper on immuno-oncology explores the challenges and opportunities in emerging markets, with a focus on Asia.

This is the final part in the series where we interviewed key opinion leader physicians and payers to explore how new oncology products are likely to fare clinically and financially. In Part 1 we looked at the current situation in the US and in part 2 we explored how the situation is developing in the EU. 

Download parts 1, 2 and 3:

16th May 2016



Company Details

Research Partnership

+44 (0)20 8069 5000

Contact Website

Chester House
Fulham Green
81-83 Fulham High Street
United Kingdom